In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia ...

WEBVTT NEW HABITAT IS SAFE. >> THEY SHOULDN’T BE NERVOUS. THE ZOO IS STILL A VERY SAFE PLACE TO VISIT. REPORTER: AS VALERIO THE JAGUAR AND THE NEW SAFETY FEATURES INSIDE HIS HABITAT WERE INTRODUCED TO ...

Jaguar Animal Health Inc. ( (JAGX)) has released its Q3 earnings. Here is a breakdown of the information Jaguar Animal Health Inc. presented to its investors. Jaguar Health Inc. is a pharmaceutical ...

SAN FRANCISCO, CA / ACCESS Newswire / August 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”), under its Jaguar Animal Health tradename for the veterinary market, today announced it is ...

Contract Secured in Preparation for Pivotal Trial & Expected Launch of Jaguar's Prescription Drug Candidate, Canalevia, for Acute Diarrhea in Dogs Jaguar to Leverage Patheon's Experience Manufacturing ...

SAN FRANCISCO--(BUSINESS WIRE)--Jaguar Animal Health, Inc. ("Jaguar" or the "Company"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for ...

Please standby, we're about to begin. Before I turn the call over to management, I'd like to remind you that management may make forward-looking statements relating to such matters as continued growth ...

Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for ...

“Specifically, our objective is to partner with an animal health company to achieve three parallel goals for Canalevia: Expand the U.S. indication from CID in dogs to treatment of general diarrhea in ...